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Neurosurgical Praxis Guidelines during the COVID-19 Outbreak. Consensusbased on currently available literature.
Abstract
INTRODUCTION: The World Health Organization recommended several strategies to contain the COVID-19
pandemic, including optimization of care for all patients, especially the seriously ill. Given the strain, the
pandemic has posed on healthcare systems around the world, many neurosurgical associations have
provided triage recommendations for patients to save resources for the pandemic. We aimed to provide
practical recommendations based on specific illnesses requiring surgical procedures commonly
performed by neurosurgeons on a life-threatening basis of patient illness. We consider this guideline will
help neurosurgeons for the appropriate triage of patients on a daily-situation basis during this pandemic.
METHODS: The Mexican Society of Neurological Surgery integrated a special COVID-19 guidelines
Committee to develop a guideline based on a three-tier route to a consensus using a modified Delphi
Method.
RESULTS: We found twenty-nine papers relating to surgical praxis recommendations since the COVID-19
outbreak in December 2019. Five reports made a classification for the priority of emergencies based on
illness severity and the time that could be elapsed to provide surgical care to avoid becoming a lifethreatening illness. From those, we chose the classification made in Lombardi, Italy related to oncology
patients in neurosurgery (Table 1). We adapted the Lombardy Classification to all neurosurgical
specialties (Table 2). Appendix 1 shows tables universally applying the modified Lombardy classification
to each of the neurosurgical subspecialties. Six papers gave specific recommendations on surgical room
setting and personal equipment protection. We made a summary of recommendations in Appendix 2. we
recommend adding a compliment to the informed consent of the surgical procedure relating to the
COVID-19 outbreak. This complement can be consulted in Appendix 3.
CONCLUSIONS: We present the following recommendations provided that we are in a very early stage of
the illness knowledge, and further research is needed to increase the certainty of recommendations. For
specific situations not covered in this document, we encourage individual hospitals to trust in the local
neurosurgeon criteria. Provided that situations and patient characteristics are highly variable, the local
neurosurgeon will always have the last word in every case as he/she is in close contact with the patient
and its medical records.
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Abstract
Introduction: The World Health Organization recommended several strategies to contain the COVID-19 pandemic,
including optimization of care for all patients, especially the seriously ill. Given the strain, the pandemic has posed on
healthcare systems around the world, many neurosurgical associations have provided triage recommendations for patients to save resources for the pandemic. We aimed to provide practical recommendations based on speciﬁc illnesses
requiring surgical procedures commonly performed by neurosurgeons on a life-threatening basis of patient illness. We
consider this guideline will help neurosurgeons for the appropriate triage of patients on a daily-situation basis during
this pandemic.
Methods: The Mexican Society of Neurological Surgery integrated a special COVID-19 guidelines Committee to
develop a guideline based on a three-tier route to a consensus using a modiﬁed Delphi Method.
Results: We found twenty-nine papers relating to surgical praxis recommendations since the COVID-19 outbreak in
December 2019. Five reports made a classiﬁcation for the priority of emergencies based on illness severity and the time
that could be elapsed to provide surgical care to avoid becoming a life-threatening illness. From those, we chose the
classiﬁcation made in Lombardy, Italy related to oncology patients in neurosurgery (Table 1). We adapted the Lombardy
Classiﬁcation to all neurosurgical specialties (Table 2). Appendix 1 shows tables universally applying the modiﬁed
Lombardy classiﬁcation to each of the neurosurgical subspecialties. Six papers gave speciﬁc recommendations on surgical room setting and personal equipment protection. We made a summary of recommendations in Appendix 2. We
recommend adding a compliment to the informed consent of the surgical procedure relating to the COVID-19 outbreak.
This complement can be consulted in Appendix 3.
Conclusions: We present the following recommendations provided that we are in a very early stage of the illness
knowledge, and further research is needed to increase the certainty of recommendations. For speciﬁc situations not
covered in this document, we encourage individual hospitals to trust in the local neurosurgeon criteria. Provided that
situations and patient characteristics are highly variable, the local neurosurgeon will always have the last word in every
case as he/she is in close contact with the patient and its medical records.
Keywords: COVID-19, SARS-CoV2, Neurosurgery guideline, AGREE Statement, Surgical room recommendations,
Personal protection equipment recommendations, Triage recommendations

1. Background

T

he World Health Organization (WHO) recognized the COVID-19 outbreak as a pandemic
on March 11, 2020 [1]. This organism recommended
several strategies to contain the disease, including
optimization of care for all patients, especially the
seriously ill [2]. Given the strain, the pandemic has

Abbreviations
COVID-19
CSF
NOM
RT
SARS-CoV2
SSA
WHO

Coronavirus Disease 19
Cerebrospinal Fluid
Ofﬁcial Mexican Norm
Radiotherapy
Severe Acute Respiratory Syndrome by
Coronavirus 2
Health Secretary of Mexico
World Health Organization
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posed on healthcare systems around the world [1],
many neurosurgical associations (among other
specialties) have provided triage recommendations
for patients to save resources for the pandemic
[3e8]. As a result, emergency surgeries were prioritized over elective surgeries in a life threateningrisk stratiﬁcation of illnesses. Nevertheless, priority
criteria were non-standardized over the associations. We aimed to provide practical recommendations based on speciﬁc illnesses requiring surgical
procedures commonly performed by neurosurgeons on a life-threatening basis of patient illness.
We consider this guideline will help neurosurgeons
for the appropriate triage of patients on a daily-situation basis during this pandemic.

2. Methods
The Mexican Society of Neurological Surgery proposed to develop these guidelines based on currently
available information since starting of the COVID-19
outbreak. To meet this purpose, the President of the
Society urged for the formation of a Special COVID19 guidelines Committee integrated by the Presidents (leaders) of the different sections (specialties)
and members of the Advisory, Scientiﬁc, and Directive Committees of the Society. A three-tier route to
consensus was made in this modiﬁed Delphi Method.
The ﬁrst stage included a comprehensive review of
current literature since the initial COVID-19
Outbreak in December 31st, 2019 to June 1st, 2020,
carried out by each of the members conforming to the
Special COVID-19 guidelines committee. Consulted
databases included PubMed and Google® Scholar;
speciﬁc medical, surgical and neurosurgical association websites were also consulted (Including the
World health organization, The American Association of Neurological Surgeons, The American College
of Surgeons, The European Association of Neurological Surgeons); other medical association websites
consulted were the result of searching COVID-19
guidelines on common search engines such as Google® (provided that some guidelines are only published in medical association websites and not in
scientiﬁc journals); those sites are cited in references.
The search words included COVID-19, SARS-CoV2,
COVID-19 outbreak, COVID-19 pandemic, triage
recommendations, neurosurgery practice guidelines,
surgical recommendations, subspecialty (spine, pediatrics, functional neurosurgery, oncology, radiosurgery, vascular, epilepsy, endovascular surgery
recommendations, surgical room recommendations,
personal equipment protection recommendations,
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surgical safety recommendations, and the different
combinations among them. The second tier included
a symposium to discuss gathered information to
agree on the crucial point of the guidelines, including
a position on a recommendation to defer or continue
elective surgery, triage protocol for patient care, a
classiﬁcation system for staging priority of emergencies, optimal surgical room setting up during
outbreak and protection equipment recommendations during the outbreak. The third tier included
using the selected classiﬁcation method to allocate
subspecialty illnesses and procedures in each category. It will help decide whether to proceed or defer
neurosurgical care based on the patient's needs and
severity while protecting patients and physicians
from unneeded exposure until the outbreak is contained. After completing the three-tier consensus, a
manuscript containing a summary of information
was developed and made readily available for all
members while this paper was published. The current guidelines adhere to the AGREE statement [9].

3. Results
We found twenty-nine papers [4e8,10e33] relating
to surgical praxis recommendations since the COVID19 outbreak in December 2019. Five reports
[4,13,14,17,31] made a classiﬁcation for the priority of
emergencies based on illness severity and the time that
could be elapsed to provide surgical care to avoid
becoming a life-threatening illness. From those, we
chose the priority criteria used for neurosurgical patients dealing with oncological pathology made in
Lombardy, Italy by Zoia et Al., here referred as the
Lombardy Classiﬁcation [14] (Table 1). We adapted
(with permission from Springer Nature®) the Lombardy Classiﬁcation by Zoia et al. [14] to all neurosurgical specialties resulting in the classiﬁcation for
Table 1. Priority criteria used for neurosurgical patients dealing with
oncological pathology in Lombardy, Italy by Zoia et al. (here referred as
the Lombardy Classiﬁcation) reproduced with permission from Springer
Nature from Zoia et al. [14].
Dealing with oncological pathology, priority criteria have been
deﬁned:
1) Class A þþ (requiring immediate treatment): patients with
intracranial or spinal oncological pathology that need emergency
treatment (rapidly evolving intracranial hypertension with
deteriorating state of consciousness, acute hydrocephalus, spinal
cord compression with rapid tetra- or paraparesis).
2) Class A þ (requiring treatment within a maximum of 7-10
days): patients with oncological pathology (intracranial tumors
with mass effect or with progressive neurological deﬁcit,
without deterioration of consciousness).
3) Class A (requiring treatment within a month): patients with
oncological neurosurgical pathology that appears radiologically
of suspected malignant nature or with oncological pathology
that determines a neurological deﬁcit.
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Table 2. The classiﬁcation for Priority Associated with Neurosurgical illnesses During pandEMICs (The PANDEMIC Classiﬁcation) [Modiﬁed
classiﬁcation for universal neurosurgical application from the priority criteria used for neurosurgical patients dealing with oncological pathology in
Lombardy, Italy by Zoia et al. here referred as the Lombardy Classiﬁcation; adapted with permission from Springer Nature® from Zoia et al. [14]].
1) PANDEMIC PRIORITY LEVEL-1 (PPL-1), illness requiring (or) emergent surgical procedure, to be performed within 24 h because of
life-threatening risk.
2) PANDEMIC PRIORITY LEVEL-2 (PPL-2), illness requiring (or) urgent surgical procedure, to be performed within a week*x because
of potentially life-threatening risk or progressive neurological deﬁcit.
3) PANDEMIC PRIORITY LEVEL-3 (PPL-3), illness requiring (or) prioritized surgical procedure, to be performed within a month**x
because of neurological deﬁcit and functional risk.
4) PANDEMIC PRIORITY LEVEL 4 (PPL-4), any illness not meeting the above criteria is considered an elective surgical procedure, and
should be delayed under surveillance until the outbreak is controlled øx.
*PPL-2 patients must be offered surgical treatment as soon as possible according to hospital capacity and should be managed as inpatients.
In the case that no surgical treatment has been provided within a week, the patient must be re-evaluated and re-classiﬁed either as Class
PPL-1 or PPL-2 according to the current medical status. At the discretion of the attending neurosurgeon when no surgical treatment is
expected to be provided soon, certain PPL-2 patients can be managed as outpatient provided that treatment is not affected, appropriate
follow-up and counseling about when to seek emergent care is given, the morbidity risk does not increase, and no factors that prevent
proper surveillance are identiﬁed (for example, living alone with no caregiver or family member to provide in-home surveillance, limited
access to the healthcare system, suspecting difﬁculty following the medical recommendations provided, among other causes).
**PPL-3 patients must be re-evaluated and re-classiﬁed every two weeks, and should be managed ambulatory.
Ø PPL-4 patients should be provided with a scheduled follow-up at the discretion of the attending neurosurgeon with proper counseling to
identify neurological symptoms that require emergent re-evaluation of illness priority during the pandemic.
xPatients must be re-evaluated and re-classifed any time as required by aggravating illness, neurological progressive deterioration or any
other patient characteristics urging its treatment.
¥ The use of personal equipment protection (PEP) including an N95 or KN95 mask, goggles, and a sterile biosafety full coverage suit is
mandatory for all the personnel involved in the surgical treatment of patients conﬁrmed or suspected to have infection by the pandemic
infectious agent.

Priority Associated with Neurosurgical illnesses During pandEMICs (The PANDEMIC Classiﬁcation)
(Table 2). Appendix 1 shows tables applying the
PANDEMIC Classiﬁcations to each of the neurosurgical subspecialties; additional references were consulted to correctly prioritize illnesses on each of the
tables [34e68]. Other speciﬁc cases, not mentioned in
these tables, but potentially life-threatening or at
functional risk, are left to be classiﬁed at the discretion
of the treating neurosurgeon. Elective procedures are
to be re-scheduled under surveillance up until the
outbreak is controlled. The current guidelines apply to
every patient, either if the patient's test results COVID19 positive or negative; this is in accordance to protect
patients and physicians from unneeded exposure,
every speciﬁc case should be revised by the attending
neurosurgeon, who has the ultimate decision.
Six papers [15,24e28] gave speciﬁc recommendations on surgical room setting and personal equipment protection. We made a summary of
recommendations in Appendix 2.
Finally, performing an emergent surgery in a patient
theoretically increases the risk of COVID-19 infection
by immunocompromise if exposed. Given that our
country does not perform broad screening and that a
signiﬁcant number of people are asymptomatic, we
consider this issue to be of utmost importance. Besides, even if broad screening were performed, it
would represent a transversal screening, and status
could change unnoticed overtime. To solve this issue,
we recommend adding a compliment to the informed
consent of the surgical procedure relating to the

COVID-19 outbreak. This complement can be consulted in Appendix 3.
Our main limitation is represented by the early
stage of the outbreak and the knowledge we have
about COVID-19. The current guidelines follow the
WHO recommendations to contain the outbreak and
provide optimization of care to those severely ill,
aiming to avoid unnecessary exposure and collapse of
the healthcare systems. The present guidelines will
serve as a cornerstone to ﬁght the pandemic while
increasing knowledge is gathered. Further research
on the socioeconomic and health impact of COVID19 will help increase the certainty and precision of the
recommendations provided, as well as to provide
updates in case required as the outbreak is contained
or the WHO recommendations change. To counter
these limitations, we submitted the manuscript to
peer-review under the journal reviewing process.
The guideline is intended to be used in a voluntary basis, by no means it represents a mandatory
application. Institutions are encouraged to review
the guidelines and use them under their own responsibility, and understanding it is based on the
very little knowledge we have about COVID-19
disease provided that we are in an early stage of the
pandemic. Therefore, no monitoring auditing
criteria to its application is provided.

4. Conclusions
We present the following recommendations
provided that we are in a very early stage of the
illness knowledge, and further research is needed
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to increase the certainty of recommendations. For
speciﬁc situations not covered in this document,
we encourage individual hospitals to trust in the
local neurosurgeon criteria. Provided that situations and patient characteristics are highly
variable, the local neurosurgeon will always have
the last word in every case as he/she is in close
contact with the patient and its medical records.
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guidelines, they must always have the appropriate
equipment to protect themselves. A sick doctor not
only represents a great individual health threat but
also means one less warrior that could help more
people in this brutal ﬁght against the pandemic.
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Publication comment
Publication comment # 1
The COVID-19 disease has undoubtedly changed
many paradigms regarding communal life. Today
we realize that interdependence is the fuel that allows the growth and development of all the societies, from families to countries and continents. The
home conﬁnement to which the SARS COV-2 virus
has forced us has stopped the economic, social,
scientiﬁc, and global growth. This situation has also
affected the quality of medical care. Firstly, due to
hospitals saturation by patients suffering from this
terrible disease, and secondly, due to the risk of
continuing to spread it when medically treating
asymptomatic infected patients suffering from other
problems.
For all of the above, precise rules must be established to know which conditions have priority to be
treated in these difﬁcult times. The Mexican Society
of Neurological Surgery, led by its president, Dr.
José Antonio Soriano Sánchez, presents in this
valuable article, the guidelines that all neurosurgeons must follow when facing patients during this
pandemic. The work is based on a meticulous review of international publications in this regard, but
faithfully adapting it to our reality.It is essential to
add that regardless of whether doctors follow these

́

Publication comment #2
“...I read with great interest the manuscript by
Soriano S
anchez and colleagues “Neurosurgical
Praxis Guidelines during the COVID-19 Outbreak.
Consensus-based on currently available literature”.
With these guidelines, the Mexican Society of
Neurological Surgery supplied compelling insights
to neurosurgeons on a broad range of illnesses
about the decision making that is required during
the current worldwide health crisis. This article
provides relevant information about the management of neurosurgical patients during the COVID19 pandemic, not only to health professionals as
individuals but at the level of institutions and
related societies. Although the guidelines are based
on the Lombardi classiﬁcation, the guidelines proposed by Soriano S
anchez et al. provide a larger
number of recommendations based on a more
detailed description of neurosurgical subspecialties
than the precedent classiﬁcation. I am certain that
these guidelines will prove to be helpful not only
during the current sanitary situation but also in
future medical emergencies and disasters.
Pablo Andrade, M.D., Ph.D.
Consultant Neurosurgeon
Department of Stereotactic and Functional Neurosurgery
University Hospital of Cologne
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APPENDIX 1
Spine surgery. The classiﬁcation for Priority Associated with Neurosurgical illnesses During pandEMICs (The PANDEMIC
Classiﬁcation) applied to Spine Surgery, provided in relation to the COVID-19 pandemic.
PANDEMIC CLASSIFICATION

ILLNESS/PROCEDURE

PANDEMIC PRIORITY LEVEL-1 (PPL-1)
illness requiring (or) emergent surgical procedure, to be
performed within 24 h because of life-threatening risk.

 Rapidly progressive~ and/or acute myelopathy of any cause:
(infection, tumor, fracture, deformity and/or herniated disc)
 Cauda equina syndrome from any cause: (infection, tumor, fracture and/or herniated disc)
 Acute radiculopathy with a motor deﬁcit of any cause: (infection,
tumor, fracture and/or herniated disc)
 Spine instability at risk of causing neurological injury from any
cause: (traumatic, tumor and/or infectious)
 Acute or unstable fractures (osteoporosis/metastatic) with
neurological deterioration, and/or intractable pain refractory to
medical treatment)
 Epidural abscess that requires surgical decompression.
 Surgical, deep, and/or dehiscent wound infections with soft tissue
involvement or systemic spread of infection.
 Acute osteomyelitis/discitis with negative blood culture and
positive acute phase reactants
 Cerebrospinal ﬂuid ﬁstula
 Immediate postsurgical complications with neurological deterioration or intractable pain refractory to medical and/or algological
treatment.
 All types of Spinal Trauma

PANDEMIC PRIORITY LEVEL-2 (PPL-2)
*x
illness requiring (or) urgent surgical procedure, to be
performed within a week*x because of potentially lifethreatening risk or progressive neurological deﬁcit.

 Chronic cervical or thoracic myelopathy with neurological progression of any cause: (tumor, traumatic and/or degenerative)
 Spinal infection (eg, discitis, osteomyelitis, epidural abscess) that
does not respond to medical treatment
 Compression of neural structures with or without deformity
(scoliosis with a neurological deﬁcit (distinguished from “severe
neurological deﬁcit” that is classiﬁed as PPL-1)
 Intractable pain associated with functional limitation and/or
excessive opioid use (herniated disc, fractures and/or progressive
deformity).

PANDEMIC PRIORITY LEVEL-3 (PPL-3)
**x
illness requiring (or) prioritized surgical procedure, to be
performed within a month**x because of neurological deﬁcit
and functional risk.

 Degenerative diseases of the spine associated with pain and
functional limitation susceptible to post-contingency management (herniated disc, spinal stenosis, spondylolisthesis)
 Revision surgery in patients with pain that responds to algological
medical treatment. (failed lumbar surgery, adjacent segment disease)
 Deformity correction surgery (scoliosis, kyphosis)

PANDEMIC PRIORITY LEVEL-4 (PPL-4)
øx
any illness not meeting the above criteria is considered an
elective surgical procedure, and should be delayed under
surveillance until the outbreak is controlled øx

 Illnesses requiring elective procedures are not speciﬁed. For
speciﬁc situations not covered in this document, we encourage
individual hospitals to trust in the local neurosurgeon criteria.
Provided that situations and patient characteristics are highly
variable, the local neurosurgeon will always have the last word in
every case as he/she is in close contact with the patient and its
medical records to properly classify the priority.
~ the loss of toilet training, provides poor functional prognosis.

*PPL-2 patients must be offered surgical treatment as soon as possible according to hospital capacity and should be managed as inpatients.
In the case that no surgical treatment has been provided within a week, the patient must be re-evaluated and re-classiﬁed either as Class
PPL-1 or PPL-2 according to the current medical status. At the discretion of the attending neurosurgeon when no surgical treatment is
expected to be provided soon, certain PPL-2 patients can be managed as outpatient provided that treatment is not affected, appropriate
follow-up and counseling about when to seek emergent care is given, the morbidity risk does not increase, and no factors that prevent
proper surveillance are identiﬁed (for example, living alone with no caregiver or family member to provide in-home surveillance, limited
access to the healthcare system, suspecting difﬁculty following the medical recommendations provided, among other causes).
**PPL-3 patients must be re-evaluated and re-classiﬁed every two weeks, and should be managed ambulatory.
Ø PPL-4 patients should be provided with a scheduled follow-up at the discretion of the attending neurosurgeon with proper counseling
to identify neurological symptoms that require emergent re-evaluation of illness priority during the pandemic.
xPatients must be re-evaluated and re-classiﬁed any time as required by aggravating illness, neurological progressive deterioration or
any other patient characteristics urging its treatment.
¥ The use of personal equipment protection (PEP) including an N95 or KN95 mask, goggles, and a sterile biosafety full coverage suit is
mandatory for all the personnel involved in the surgical treatment of patients conﬁrmed or suspected to have infection by the pandemic
infectious agent.
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Functional, epilepsy and peripheral nerve surgery. The classiﬁcation for Priority Associated with Neurosurgical
illnesses During pandEMICs (The PANDEMIC Classiﬁcation) applied to Functional Epilepsy and Peripheral Nerve Surgery, provided in
relation to the COVID-19 pandemic. Neuroendoscopy. The classiﬁcation for Priority Associated with Neurosurgical illnesses During
pandEMICs (The PANDEMIC Classiﬁcation) applied to Neuroendoscopy, provided in relation to the COVID-19 pandemic.
PANDEMIC CLASSIFICATION
PANDEMIC PRIORITY LEVEL-1 (PPL-1)
illness requiring (or) emergent surgical procedure, to be
performed within 24 h because of life-threatening risk.

ILLNESS/PROCEDURE









Super-refractory multifocal status epilepticus
Super-refractory focal status epilepticus
Continuous partial epilepsy
Status epilepticus of febrile infection related to an epileptic
syndrome
Hardware infection
Sudden battery failure
Traumatic plexus injury
Open traumatic injuries of peripheral nerves

PANDEMIC PRIORITY LEVEL-2 (PPL-2)
*x
illness requiring (or) urgent surgical procedure, to be
performed within a week*x because of potentially lifethreatening risk or progressive neurological deﬁcit.

 Stereostatic biopsies
 Disconnection and lesion surgeries for epilepsy

PANDEMIC PRIORITY LEVEL-3 (PPL-3)
**x
illness requiring (or) prioritized surgical procedure, to be
performed within a month**x because of neurological deﬁcit
and functional risk.






PANDEMIC PRIORITY LEVEL-4 (PPL-4)
øx
any illness not meeting the above criteria is considered an
elective surgical procedure, and should be delayed under
surveillance until the outbreak is controlled øx

 Illnesses requiring elective procedures are not speciﬁed. For
speciﬁc situations not covered in this document, we encourage
individual hospitals to trust in the local neurosurgeon criteria.
Provided that situations and patient characteristics are highly
variable, the local neurosurgeon will always have the last word in
every case as he/she is in close contact with the patient and its
medical records to properly classify the priority.

Parkinson's, abnormal movements
Psychosurgery
Non-lesional epilepsy surgery
Plexus Exploration

*PPL-2 patients must be offered surgical treatment as soon as possible according to hospital capacity and should be managed as inpatients.
In the case that no surgical treatment has been provided within a week, the patient must be re-evaluated and re-classiﬁed either as Class
PPL-1 or PPL-2 according to the current medical status. At the discretion of the attending neurosurgeon when no surgical treatment is
expected to be provided soon, certain PPL-2 patients can be managed as outpatient provided that treatment is not affected, appropriate
follow-up and counseling about when to seek emergent care is given, the morbidity risk does not increase, and no factors that prevent
proper surveillance are identiﬁed (for example, living alone with no caregiver or family member to provide in-home surveillance, limited
access to the healthcare system, suspecting difﬁculty following the medical recommendations provided, among other causes).
**PPL-3 patients must be re-evaluated and re-classiﬁed every two weeks, and should be managed ambulatory.
Ø PPL-4 patients should be provided with a scheduled follow-up at the discretion of the attending neurosurgeon with proper counseling
to identify neurological symptoms that require emergent re-evaluation of illness priority during the pandemic.
xPatients must be re-evaluated and re-classiﬁed any time as required by aggravating illness, neurological progressive deterioration or
any other patient characteristics urging its treatment.
¥ The use of personal equipment protection (PEP) including an N95 or KN95 mask, goggles, and a sterile biosafety full coverage suit is
mandatory for all the personnel involved in the surgical treatment of patients conﬁrmed or suspected to have infection by the pandemic
infectious agent.

Neuroendoscopy. The classiﬁcation for Priority Associated with Neurosurgical illnesses During pandEMICs (The PANDEMIC
Classiﬁcation) applied to Neuroendoscopy, provided in relation to the COVID-19 pandemic.
PANDEMIC CLASSIFICATION
PANDEMIC PRIORITY LEVEL-1 (PPL-1)
illness requiring (or) emergent surgical procedure, to be
performed within 24 h because of life-threatening risk.

ILLNESS/PROCEDURE
 Hydrocephalus
 Syringobulbia/syringomyelia with
deterioration
 Ventricular shunt dysfunction
 Ependymitis

progressive

neurological

(continued on next page)
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(Neuroendoscopy continued )
PANDEMIC CLASSIFICATION

ILLNESS/PROCEDURE
 Germinal matrix hemorrhage
 Intraventricular hemorrhage in adults
 Endoscopic assistance in intraventricular tumors with or without
hydrocephalus.
 Intra-sellar tumors with a risk of death or loss of the mink
 Migrated or lateral spinal hernias with neurological deﬁcit or
excessive symptoms

PANDEMIC PRIORITY LEVEL-2 (PPL-2)
*x
illness requiring (or) urgent surgical procedure, to be
performed within a week*x because of potentially lifethreatening risk or progressive neurological deﬁcit.

 N/A

PANDEMIC PRIORITY LEVEL-3 (PPL-3)
**x
illness requiring (or) prioritized surgical procedure, to be
performed within a month**x because of neurological
deﬁcit and functional risk.

 Endoscopic assistance in tumors without mass effect or neurological deterioration.

PANDEMIC PRIORITY LEVEL-4 (PPL-4)
øx
any illness not meeting the above criteria is considered an
elective surgical procedure, and should be delayed under
surveillance until the outbreak is controlled øx

 Illnesses requiring elective procedures are not speciﬁed. For
speciﬁc situations not covered in this document, we encourage
individual hospitals to trust in the local neurosurgeon criteria.
Provided that situations and patient characteristics are highly
variable, the local neurosurgeon will always have the last word in
every case as he/she is in close contact with the patient and its
medical records to properly classify the priority.

*PPL-2 patients must be offered surgical treatment as soon as possible according to hospital capacity and should be managed as inpatients.
In the case that no surgical treatment has been provided within a week, the patient must be re-evaluated and re-classiﬁed either as Class
PPL-1 or PPL-2 according to the current medical status. At the discretion of the attending neurosurgeon when no surgical treatment is
expected to be provided soon, certain PPL-2 patients can be managed as outpatient provided that treatment is not affected, appropriate
follow-up and counseling about when to seek emergent care is given, the morbidity risk does not increase, and no factors that prevent
proper surveillance are identiﬁed (for example, living alone with no caregiver or family member to provide in-home surveillance, limited
access to the healthcare system, suspecting difﬁculty following the medical recommendations provided, among other causes).
**PPL-3 patients must be re-evaluated and re-classiﬁed every two weeks, and should be managed ambulatory.
Ø PPL-4 patients should be provided with a scheduled follow-up at the discretion of the attending neurosurgeon with proper counseling to
identify neurological symptoms that require emergent re-evaluation of illness priority during the pandemic.
xPatients must be re-evaluated and re-classiﬁed any time as required by aggravating illness, neurological progressive deterioration or any
other patient characteristics urging its treatment.
¥ The use of personal equipment protection (PEP) including an N95 or KN95 mask, goggles, and a sterile biosafety full coverage suit is
mandatory for all the personnel involved in the surgical treatment of patients conﬁrmed or suspected to have infection by the pandemic
infectious agent.

Neurotrauma. The classiﬁcation for Priority Associated with Neurosurgical illnesses During pandEMICs (The PANDEMIC Classiﬁcation) applied to Neurotrauma, provided in relation to the COVID-19 pandemic.
PANDEMIC CLASSIFICATION
PANDEMIC PRIORITY LEVEL-1 (PPL-1)
illness requiring (or) emergent surgical procedure, to be
performed within 24 h because of life-threatening risk.

ILLNESS/PROCEDURE
 Acute subdural hematoma
B Thickness >10 mm
B Midline deviation > 5 mm
B Midline deviation of <5 mm and thickness of <10 mm accompanied by 2-point Glasgow impairment in 1 h
B Asymmetric pupils
B Fixed and dilated pupils
B Intracranial pressure >20 mmHg
 Subacute and chronic subdural hematoma
 Patients with a subacute or chronic subdural hematoma of any
thickness that causes a mass-effect, midline displacement or neurological signs and symptoms
 Epidural hematoma
 Glasgow Coma Scale <8 and anisocoria
(continued on next page)
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(Neurotrauma continued )
PANDEMIC CLASSIFICATION

ILLNESS/PROCEDURE
 Hematoma volume> 30 cm3
 Hematoma volume of <30 cm3 accompanied by
B Thickness> 15 mm
B Midline deviation> 5 mm
B Glasgow equal to or less than 8
B Motor deﬁcit
 Absence of cisterns at the base
 2-point Glasgow decline in 1 h
 Intraparenchymal hematoma
 Frontal or temporary hematoma with a volume greater than 20 cm3
associated with:
B Glasgow Coma Scale from 6 to 8 points
B Midline offset greater than 5 mm
B Compression of the mesencephalic cisterns
 Any injury with a volume greater than 50 cm3
 Temporal lobe hematoma greater than 30 ml with or without deviation from the midline
 Sinking fracture
 Presence of open and depressed fracture in a baby or child
 Depression of the fracture segment greater than 5 mm below the
internal theca in an adult patient

PANDEMIC PRIORITY LEVEL-2 (PPL-2)
*x
illness requiring (or) urgent surgical procedure, to be
performed within a week*x because of potentially lifethreatening risk or progressive neurological deﬁcit.

 Asymptomatic
deviation.

PANDEMIC PRIORITY LEVEL-3 (PPL-3)
**x
illness requiring (or) prioritized surgical procedure, to be
performed within a month**x because of neurological
deﬁcit and functional risk.

 N/A

PANDEMIC PRIORITY LEVEL-4 (PPL-4)
øx
any illness not meeting the above criteria is considered an
elective surgical procedure, and should be delayed under
surveillance until the outbreak is controlled øx

 Illnesses requiring elective procedures are not speciﬁed. For speciﬁc
situations not covered in this document, we encourage individual
hospitals to trust in the local neurosurgeon criteria. Provided that
situations and patient characteristics are highly variable, the local
neurosurgeon will always have the last word in every case as he/she
is in close contact with the patient and its medical records to properly
classify the priority.

chronic

subdural

hematoma

without

midline

*PPL-2 patients must be offered surgical treatment as soon as possible according to hospital capacity and should be managed as inpatients.
In the case that no surgical treatment has been provided within a week, the patient must be re-evaluated and re-classiﬁed either as Class
PPL-1 or PPL-2 according to the current medical status. At the discretion of the attending neurosurgeon when no surgical treatment is
expected to be provided soon, certain PPL-2 patients can be managed as outpatient provided that treatment is not affected, appropriate
follow-up and counseling about when to seek emergent care is given, the morbidity risk does not increase, and no factors that prevent
proper surveillance are identiﬁed (for example, living alone with no caregiver or family member to provide in-home surveillance, limited
access to the healthcare system, suspecting difﬁculty following the medical recommendations provided, among other causes).
**PPL-3 patients must be re-evaluated and re-classiﬁed every two weeks, and should be managed ambulatory.
Ø PPL-4 patients should be provided with a scheduled follow-up at the discretion of the attending neurosurgeon with proper counseling to
identify neurological symptoms that require emergent re-evaluation of illness priority during the pandemic.
xPatients must be re-evaluated and re-classiﬁed any time as required by aggravating illness, neurological progressive deterioration or any
other patient characteristics urging its treatment.
¥ The use of personal equipment protection (PEP) including an N95 or KN95 mask, goggles, and a sterile biosafety full coverage suit is
mandatory for all the personnel involved in the surgical treatment of patients conﬁrmed or suspected to have infection by the pandemic
infectious agent.
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Radioneurosugery. The classiﬁcation for Priority Associated with Neurosurgical illnesses During pandEMICs (The PANDEMIC
Classiﬁcation) applied to Radioneurosurgery, provided in relation to the COVID-19 pandemic.
PANDEMIC CLASSIFICATION

ILLNESS/PROCEDURE

PANDEMIC PRIORITY LEVEL-1 (PPL-1)
illness requiring (or) emergent surgical procedure, to be
performed within 24 h because of life-threatening risk.

 Brain metastases of any cranial origin and location, including
ocular (melanomas, ocular micrometastases) in the context
that are highly symptomatic and have a life expectancy greater
than 3-6 months.
 Spinal metastasis (any origin) that generates compression
symptoms that are not a candidate for surgery.
 Palliation of pain in spinal metastases that do not respond to
pain relievers prescribed by pain clinic for a reasonable
amount of time (joint management with pain clinic) including
pain from (any origin) multiple myeloma with a life expectancy greater than 3 or 6 months.
 For pain relief in cancer patients with a thalamotomy or hypophysectomy procedure.
 Anaplastic gliomas and glioblastomas (including recurrences)
 Pituitary adenomas with malignant transformation
 Anaplastic meningiomas
 Anaplastic ependymomas
 Malignant pediatric pathology (glioblastomas, medulloblastomas, ependymomas grade III)
 Cranial and spinal malignant bone tumors. (boost & RT) with
aggressive behavior and rapid growth. (Individualize case)

PANDEMIC PRIORITY LEVEL-2 (PPL-2)
*x
illness requiring (or) urgent surgical procedure, to be
performed within a week*x because of potentially
life-threatening risk or progressive neurological deﬁcit.

 Low-grade gliomas that are considered, in a rigorous evaluation, to be treated for aggressive behavior. (including
recurrences)
 Uncontrolled trigeminal neuralgia with multiple medications
for a prolonged period of time (individualize case)

PANDEMIC PRIORITY LEVEL-3 (PPL-3)
**x
illness requiring (or) prioritized surgical procedure, to be
performed within a month**x because of neurological
deﬁcit and functional risk.

 N/A

PANDEMIC PRIORITY LEVEL-4 (PPL-4)
øx
any illness not meeting the above criteria is considered
an elective surgical procedure, and should be delayed
under surveillance until the outbreak is controlled øx

 Illnesses requiring elective procedures are not speciﬁed. For
speciﬁc situations not covered in this document, we encourage
individual hospitals to trust in the local neurosurgeon criteria.
Provided that situations and patient characteristics are highly
variable, the local neurosurgeon will always have the last
word in every case as he/she is in close contact with the patient and its medical records to properly classify the priority.

*PPL-2 patients must be offered surgical treatment as soon as possible according to hospital capacity and should be managed as inpatients. In the case that no surgical treatment has been provided within a week, the patient must be re-evaluated and re-classiﬁed either
as Class PPL-1 or PPL-2 according to the current medical status. At the discretion of the attending neurosurgeon when no surgical
treatment is expected to be provided soon, certain PPL-2 patients can be managed as outpatient provided that treatment is not affected,
appropriate follow-up and counseling about when to seek emergent care is given, the morbidity risk does not increase, and no factors
that prevent proper surveillance are identiﬁed (for example, living alone with no caregiver or family member to provide in-home
surveillance, limited access to the healthcare system, suspecting difﬁculty following the medical recommendations provided, among
other causes).
**PPL-3 patients must be re-evaluated and re-classiﬁed every two weeks, and should be managed ambulatory.
Ø PPL-4 patients should be provided with a scheduled follow-up at the discretion of the attending neurosurgeon with proper counseling
to identify neurological symptoms that require emergent re-evaluation of illness priority during the pandemic.
xPatients must be re-evaluated and re-classiﬁed any time as required by aggravating illness, neurological progressive deterioration or
any other patient characteristics urging its treatment.
¥ The use of personal equipment protection (PEP) including an N95 or KN95 mask, goggles, and a sterile biosafety full coverage suit is
mandatory for all the personnel involved in the surgical treatment of patients conﬁrmed or suspected to have infection by the pandemic
infectious agent.
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Cerebrovascular surgery and/or endovascular therapy. The classiﬁcation for Priority Associated with Neurosurgical
illnesses During pandEMICs (The PANDEMIC Classiﬁcation) applied to Cerebrovascular Surgery and/or Endovascular Therapy,
provided in relation to the COVID-19 pandemic.
PANDEMIC CLASSIFICATION

ILLNESS/PROCEDURE

PANDEMIC PRIORITY LEVEL-1 (PPL-1)
illness requiring (or) emergent surgical procedure, to be
performed within 24 h because of life-threatening risk.

 Aneurysmal subarachnoid hemorrhage
 Intracranial hemorrhage of any cause with mass effect and progressive neurological deterioration:
B Arterial hypertension
B Arteriovenous malformation
B Dural ﬁstula
B Pial Fistula
B Cavernous Angioma
 Cerebral Infarction with the need for decompression (within the
ﬁrst 48 h and with Glasgow greater than 8 in a patient younger
than 65 years)
 Carotid or vertebral vascular dissection
 Open and/or Interventional thrombectomy
 Cerebral infarction in A period of reperfusion

PANDEMIC PRIORITY LEVEL-2 (PPL-2)
*x
illness requiring (or) urgent surgical procedure, to be
performed within a week*x because of potentially lifethreatening risk or progressive neurological deﬁcit.

 Unruptured intracranial aneurysms with alarm data such as
headache, chronic headache, or blebs.
 Unruptured Arteriovenous malformations with intranidal aneurysm, drainage vein stenosis
 Incidental posterior fossa aneurysm

PANDEMIC PRIORITY LEVEL-3 (PPL-3)
**x
illness requiring (or) prioritized surgical procedure, to be
performed within a month**x because of neurological
deﬁcit and functional risk.

 Arteriovenous malformations with:
B Epilepsy difﬁcult to control
B Limited but recurrent bleeding.
 Pial and dural arteriovenous ﬁstulas with ﬂow theft that conditions rapidly progressive deterioration of functions.
 Incidental intracranial aneurysms without symptoms.

PANDEMIC PRIORITY LEVEL-4 (PPL-4)
øx
any illness not meeting the above criteria is considered an
elective surgical procedure, and should be delayed under
surveillance until the outbreak is controlled øx

 Illnesses requiring elective procedures are not speciﬁed. For
speciﬁc situations not covered in this document, we encourage
individual hospitals to trust in the local neurosurgeon criteria.
Provided that situations and patient characteristics are highly
variable, the local neurosurgeon will always have the last word in
every case as he/she is in close contact with the patient and its
medical records to properly classify the priority.

*PPL-2 patients must be offered surgical treatment as soon as possible according to hospital capacity and should be managed as inpatients.
In the case that no surgical treatment has been provided within a week, the patient must be re-evaluated and re-classiﬁed either as Class
PPL-1 or PPL-2 according to the current medical status. At the discretion of the attending neurosurgeon when no surgical treatment is
expected to be provided soon, certain PPL-2 patients can be managed as outpatient provided that treatment is not affected, appropriate
follow-up and counseling about when to seek emergent care is given, the morbidity risk does not increase, and no factors that prevent
proper surveillance are identiﬁed (for example, living alone with no caregiver or family member to provide in-home surveillance, limited
access to the healthcare system, suspecting difﬁculty following the medical recommendations provided, among other causes).
**PPL-3 patients must be re-evaluated and re-classiﬁed every two weeks, and should be managed ambulatory.
Ø PPL-4 patients should be provided with a scheduled follow-up at the discretion of the attending neurosurgeon with proper counseling
to identify neurological symptoms that require emergent re-evaluation of illness priority during the pandemic.
xPatients must be re-evaluated and re-classiﬁed any time as required by aggravating illness, neurological progressive deterioration or
any other patient characteristics urging its treatment.
¥ The use of personal equipment protection (PEP) including an N95 or KN95 mask, goggles, and a sterile biosafety full coverage suit is
mandatory for all the personnel involved in the surgical treatment of patients conﬁrmed or suspected to have infection by the pandemic
infectious agent.
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Neuro-oncology. The classiﬁcation for Priority Associated with Neurosurgical illnesses During pandEMICs (The PANDEMIC
Classiﬁcation) applied to Neurooncology, provided in relation to the COVID-19 pandemic.
PANDEMIC CLASSIFICATION

ILLNESS/PROCEDURE

PANDEMIC PRIORITY LEVEL-1 (PPL-1)
illness requiring (or) emergent surgical procedure, to be
performed within 24 h because of life-threatening risk.

 Gliomas with a high degree of malignancy (III or IV) and/or
metastasis with clinical data of acute intracranial hypertension and
facial-caudal deterioration, or those with evidence of imaging herniation with or without symptoms.
 Benign or malignant tumors with data of acute intracranial hypertension and facial-caudal deterioration or those patients with data
of image herniation with or without symptoms.
 Pituitary adenoma with tumor apoplexy and sudden loss of sight in
one or both eyes and/or acute neurological deﬁcit (paralysis of
cranial nerves III, IV, or VI). It is recommended in the case of being
COVID-19 positive or if there is doubt that it is, DO NOT perform
endoscopic approaches. Craniotomy or sublabial, transseptal,
transsphenoidal approach with the use of a microscope is recommended. The use of high-speed milling systems by the transnasal
route is not recommended. Endoscopic approaches are recommended only if it is certain that the patient is COVID-19 negative.
 Single or multiple brain abscess, subdural empyema or hydrocephalus secondary to valve dysfunction with or without suspected
ependymitis.
 Patients with a post-surgical, post-traumatic, or spontaneous highoutput cerebrospinal ﬂuid ﬁstula that did not resolve with conservative measures.
 Any immediate post-surgical complication that causes acute
neurological impairment or a new neurological deﬁcit.
 Skull base tumors that compress the brainstem and/or cause a
progressive neurological deﬁcit or compromise the function of the
cranial nerves.
 Craniofacial tumors that compromise the airway and invade the
paranasal sinuses with respiratory distress should be operated
immediately, with all the protective measures for medical-surgical
personnel, even if the COVID-19 result is not yet available.

PANDEMIC PRIORITY LEVEL-2 (PPL-2)
*x
illness requiring (or) urgent surgical procedure, to be
performed within a week*x because of potentially lifethreatening risk or progressive neurological deﬁcit.

 Gliomas with a high degree of malignancy (III or IV) or metastasis
with rapid growth, whether or not they have a neurological deﬁcit,
as well as cerebral edema that must be managed before entering
surgery but cannot wait three weeks for resolution.
 Pituitary tumors with a rapidly progressive visual deﬁcit with or
without complete compression of the third ventricle and secondary
compensated hydrocephalus. Except in cases where it is suspected
or is certain that it is Prolactinoma, in which case only hydrocephalus will resolve. It is recommended in the case of being
COVID-19 positive or if there is doubt that it is, DO NOT perform
endoscopic approaches. Craniotomy or sublabial, transeptal,
transsphenoidal approach with the use of a microscope is recommended. The use of high-speed milling systems by the transnasal
route is not recommended. Endoscopic approaches are recommended only if it is certain that the patient is COVID-19 negative.
 Posterior fossa tumors with obstruction of cerebrospinal ﬂuid circulation with or without secondary hydrocephalus or with signiﬁcant mass effect on the brainstem with or without neurological
deterioration, mainly cystic tumors, except for the epidermoid
tumor.
 Ventricular tumors that cause obstruction of the circulation of the
cerebrospinal ﬂuid and/or cause hydrocephalus. Solve hydrocephalus urgently and study the patient to schedule surgery for tumor
resection.
 Ventricular tumors that produce mass-effect, alteration of the
neurological state, and compromise the diencephalon, the midbrain
(continued on next page)
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(Neuro-oncology continued )
PANDEMIC CLASSIFICATION

ILLNESS/PROCEDURE
or the IV ventricle. If hydrocephalus is caused, it will be resolved
urgently, and the patient must be studied to schedule surgery for
tumor resection.
 Patient with a post-surgical, post-traumatic, or spontaneous lowoutput cerebrospinal ﬂuid ﬁstula that did not resolve with conservative measures.
 Infection or dehiscence of surgical wound.
 Craniofacial tumors that compromise the airway and invade the
paranasal sinuses without respiratory distress should be operated
only once the negative COVID-19 test is obtained.

PANDEMIC PRIORITY LEVEL-3 (PPL-3)
**x
illness requiring (or) prioritized surgical procedure, to be
performed within a month**x because of neurological
deﬁcit and functional risk.

 Skull base tumors that cause disabling pain such as trigeminal
neuralgia, and the patient does not respond to any medical treatment or radiosurgery.
 Patient with low-ﬂow spontaneous or posttraumatic cerebrospinal
ﬂuid ﬁstula that is active only intermittently.

PANDEMIC PRIORITY LEVEL-4 (PPL-4)
øx
any illness not meeting the above criteria is considered an
elective surgical procedure, and should be delayed under
surveillance until the outbreak is controlled øx

 Illnesses requiring elective procedures are not speciﬁed. For speciﬁc
situations not covered in this document, we encourage individual
hospitals to trust in the local neurosurgeon criteria. Provided that
situations and patient characteristics are highly variable, the local
neurosurgeon will always have the last word in every case as he/she
is in close contact with the patient and its medical records to
properly classify the priority.

*PPL-2 patients must be offered surgical treatment as soon as possible according to hospital capacity and should be managed as inpatients. In the case that no surgical treatment has been provided within a week, the patient must be re-evaluated and re-classiﬁed either
as Class PPL-1 or PPL-2 according to the current medical status. At the discretion of the attending neurosurgeon when no surgical
treatment is expected to be provided soon, certain PPL-2 patients can be managed as outpatient provided that treatment is not affected,
appropriate follow-up and counseling about when to seek emergent care is given, the morbidity risk does not increase, and no factors
that prevent proper surveillance are identiﬁed (for example, living alone with no caregiver or family member to provide in-home
surveillance, limited access to the healthcare system, suspecting difﬁculty following the medical recommendations provided, among
other causes).
**PPL-3 patients must be re-evaluated and re-classiﬁed every two weeks, and should be managed ambulatory.
Ø PPL-4 patients should be provided with a scheduled follow-up at the discretion of the attending neurosurgeon with proper counseling
to identify neurological symptoms that require emergent re-evaluation of illness priority during the pandemic.
xPatients must be re-evaluated and re-classiﬁed any time as required by aggravating illness, neurological progressive deterioration or
any other patient characteristics urging its treatment.
¥ The use of personal equipment protection (PEP) including an N95 or KN95 mask, goggles, and a sterile biosafety full coverage suit is
mandatory for all the personnel involved in the surgical treatment of patients conﬁrmed or suspected to have infection by the pandemic
infectious agent.

Pediatrics neurosurgery. The classiﬁcation for Priority Associated with Neurosurgical illnesses During pandEMICs (The
PANDEMIC Classiﬁcation) applied to Peaditrics Neurosurgery, provided in relation to the COVID-19 pandemic.
PANDEMIC CLASSIFICATION

ILLNESS/PROCEDURE

PANDEMIC PRIORITY LEVEL-1 (PPL-1)
illness requiring (or) emergent surgical procedure, to be
performed within 24 h because of life-threatening risk.

 Of the newborn at term and preterm.
 Broken myelomeningocele (includes myeloschisis).
 Posthemorrhagic hydrocephalus of prematurity with rapidly
progressive growth of the cephalic girth.
 Congenital hydrocephalus. With head circumference equal to or
greater than 45 cm
 Other symptomatic hydrocephalus or cerebrospinal ﬂuid collections with signs and symptoms of intracranial hypertension.
 Acute hydrocephalus of etiology to be determined.
 Obstructive hydrocephalus, secondary to midline tumor (anterior, middle, or posterior fossa).
(continued on next page)
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(Pediatrics neurosurgery continued )
PANDEMIC CLASSIFICATION

ILLNESS/PROCEDURE











 Hydrocephalus secondary to valve dysfunction.
 Post-traumatic or post-infectious hygromas, with a thickness
greater than 10 mm, that produce symptoms and signs of intracranial hypertension.
 Broken arachnoid cysts with acute intracystic bleeding that
condition symptoms and signs of intracranial hypertension
Cranioencephalic trauma
B Acute, subacute, or chronic subdural hematomas greater than 10
mm, with midline deviation and producing symptoms and signs
of intracranial hypertension.
B Epidural hematoma: Glasgow modiﬁed for the pediatric patient
<12 points, with anisocoria and/or hemiparesis, thickness> 10
mm with deviation of midline structures, hemoglobin depletion
<12 gr.
B Exposed skull fracture c/without CSF ﬁstula or exposure of brain
tissue.
B Sunken fracture greater than> 5 mm
Vascular
B Parenchymal hematoma secondary to rupture of arteriovenous
malformation with a deviation of midline or aneurysmal
structures
Neuro-oncology
B Tumors of the posterior fossa that condition the displacement of
the brain stem. Except for brainstem gliomas and other midline
gliomas.
B Tumors in the cerebral hemispheres that due to their volume (>3
or 4 cm in diameter), or perilesional edema produce a deviation
of the structures of the midline with neurological deﬁcit and/or
intracranial hypertension. Except for midline gliomas (hypothalamic, visual or thalamic).
Pediatric column
B Fracture with or without vertebral dislocation with spinal
compression that conditions neurological deﬁcit.
B Intra-spinal tumors that condition intra or extramedullary
medullary compression, with progressive neurological deterioration (progressive decrease in the strength of the lower extremities and/or urinary retention secondary to the neuropathic
bladder) that puts the function at risk.
Infections
B Infected surgical wounds
B Subdural empyema
B c) Brain abscess equal to or greater than 3 cm in diameter.

PANDEMIC PRIORITY LEVEL-2 (PPL-2)
*x
illness requiring (or) urgent surgical procedure, to be
performed within a week*x because of potentially lifethreatening risk or progressive neurological deﬁcit.

 N/A

PANDEMIC PRIORITY LEVEL-3 (PPL-3)
**x
illness requiring (or) prioritized surgical procedure, to be
performed within a month**x because of neurological
deﬁcit and functional risk.

 N/A

(continued on next page)
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(Pediatrics neurosurgery continued )
PANDEMIC CLASSIFICATION

ILLNESS/PROCEDURE

PANDEMIC PRIORITY LEVEL-4 (PPL-4)
øx
any illness not meeting the above criteria is considered an
elective surgical procedure, and should be delayed under
surveillance until the outbreak is controlled øx

 Illnesses requiring elective procedures are not speciﬁed. For speciﬁc
situations not covered in this document, we encourage individual
hospitals to trust in the local neurosurgeon criteria. Provided that
situations and patient characteristics are highly variable, the local
neurosurgeon will always have the last word in every case as he/she
is in close contact with the patient and its medical records to
properly classify the priority.

*PPL-2 patients must be offered surgical treatment as soon as possible according to hospital capacity and should be managed as inpatients. In the case that no surgical treatment has been provided within a week, the patient must be re-evaluated and re-classiﬁed either
as Class PPL-1 or PPL-2 according to the current medical status. At the discretion of the attending neurosurgeon when no surgical
treatment is expected to be provided soon, certain PPL-2 patients can be managed as outpatient provided that treatment is not affected,
appropriate follow-up and counseling about when to seek emergent care is given, the morbidity risk does not increase, and no factors
that prevent proper surveillance are identiﬁed (for example, living alone with no caregiver or family member to provide in-home
surveillance, limited access to the healthcare system, suspecting difﬁculty following the medical recommendations provided, among
other causes).
**PPL-3 patients must be re-evaluated and re-classiﬁed every two weeks, and should be managed ambulatory.
Ø PPL-4 patients should be provided with a scheduled follow-up at the discretion of the attending neurosurgeon with proper counseling
to identify neurological symptoms that require emergent re-evaluation of illness priority during the pandemic.
xPatients must be re-evaluated and re-classiﬁed any time as required by aggravating illness, neurological progressive deterioration or
any other patient characteristics urging its treatment.
¥ The use of personal equipment protection (PEP) including an N95 or KN95 mask, goggles, and a sterile biosafety full coverage suit is
mandatory for all the personnel involved in the surgical treatment of patients conﬁrmed or suspected to have infection by the pandemic
infectious agent.

APPENDIX 2
Bioprotection protocol in neurological surgery.
For the pandemic COVID-19.
1) We are entering a phase of community transmission, where the number of daily tests performed is
insufﬁcient to meet our population needs. As a result, all patients with suggestive symptoms should be
considered COVID-19 positive until proven otherwise and should apply all protective measures for
positive patients, even without a conﬁrmatory diagnosis. In the case of asymptomatic patients, all should
be considered suspicious, and the protection measures listed below will also be taken, if possible.
2) It is recommended to reduce the activity and daily clinical practice to the minimum necessary and suspend
scheduled activities such as consultation and elective surgeries, adhering to the classiﬁcation of urgent
surgeries in this COVID-19 pandemic as referred to on appendix 1.
Patient care before and after operating room.
1) It is recommended to wear exclusive clothing for the hospital and change it when leaving the hospital.
2) Frequent cleaning of cell phones, pens, and other accessories should be carried out.
3) Inpatient care at a distance greater than 1.5 m away, a 3-layer mouthpiece must be used; under these
circumstances, the use of the N95 NIOSH mask or NK95 is not necessary, nor the use of surgical gown
and hat. If there is no contact with the patient or any potentially contaminated surface, the use of gloves
is unnecessary.
4) When patient care with less than 1.5 m away is required (neurological exploration), full protection
is advised. It is recommended to use N95 NIOSH/NK95 mouth covers, surgical or disposable gown
(labeled with moderate or high protection barrier), cap, hermetic googles, protection mask, and
gloves (it is not necessary to use a second pair).
5) The gown must overlap enough at the back to ensure that it completely covers the entire surface of the
body, especially the back, and take special care that when the person who wears it bends or sits down, it
remains wholly covered at the rear.
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6) The procedure for putting on and taking off Personal Protective Equipment (PPE) must be known.
Personnel training is recommended in order to avoid contamination at the time of carrying out the
procedure.
7) Full protective suits, while providing 360-degree protection, are recommended for personnel transporting patients. They should be very familiar with the process of removing the suit due to the increased
risk of contamination.
8) Access to soap, sanitary napkins, and antibacterial gel should be widely available without limitations in
all areas.
9) It is suggested not to wear a beard since the virus can remain there for up to 12 h, and the sealing of the
masks is not adequate.
Care of the patient within the operating room.
1) All personnel must be trained and know the biosecurity measures.
2) An operating room and an exclusive anesthesia machine should be used for Covid-19 positive patients.
3) It should be ensured that an exhaustive cleaning protocol is carried out in the operating room at the end
of the previous surgical procedure, with a waiting time of at least 30 min before using it.
4) Ideally, we recommend to have an operating room with negative pressure ventilation; however, we
do not have this technology in many hospitals, so sufﬁcient time should be left between cases for
adequate air exchange, generally 30 min. In this situation, it is recommended that the room has a
laminar ﬂow that works properly, as well as a positive pressure system so that air movement occurs
from the cleanest area to the least clean area. (from the inside out).
5) Clinical records and telephones should be left out of the operating room.
6) All devices used in the operating room (for example, a microscope or electrocautery) will be protected
with disposable covers.
7) An exclusive circulating agent will be assigned outside the operating room to provide the required
material through the whole procedure.
8) Avoid as far as possible to be less than 1.5 m from the patient when performing intubation and extubation of the patient. (All personnel not required for the said procedure must remain outside the room)
9) Clean the surface after the intubation process before continuing with the routine of the surgical
procedure.
10) It is recommended to have the presence within the operating room of only the personnel necessary to
carry out the surgical procedure. The personnel who will be inside (anesthesiologists, circulating nurses)
move as little as possible to avoid forming air currents inside the operating room.
11) It is recommended to reduce to at most the procedures in which there is an emission of aerosol particles.
To meet this goal, tracheotomies, access to the paranasal sinuses, endoscopic transsphenoidal procedures, drilling within or near the nasal cavity (cranial surgery at risk of opening paranasal sinuses), and
the use electrocoagulation should be avoided as far as possible.
12) Carry out the usual hand washing before surgery and carry out hand washing at the end of the surgical
procedure.
13) Use waterproof surgical clothing (ﬁelds and sheets) and disposable equipment (bipolar forceps and
electrocautery cables) whenever possible.
14) Use standard PPE for patients with a high risk of contagiousness: waterproof surgical gown, hermetic
googles, and N95 NIOSH/NK95 surgical masks (without an exhalation valve). For surgical procedures, it
is recommended to use a second pair of gloves to avoid contamination if they break.
15) Ensure adequate disposal of the surgical material used, the protective equipment, and the airways'
material.
16) All personnel should bathe and change after the procedure.
17) These recommendations were developed in order to provide a management guide for Covid-19 patients
undergoing Neurosurgical management.
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APPENDIX 3
Annex of informed consent for the risk of contagious of infecto-contagious diseases in speciﬁc COVID-19.
(In accordance with nom 004/SSA3/2012).
Risks.
You are informed that during your hospital stay and during the time of your intervention, procedure
and/or treatment that it is: ________________________________,
You will be at risk of contracting COVID-19 due to the current pandemic. The COVID-19 illness, is the
result of a highly contagious viral infection, a virus who was ﬁrst reported in Wuhan, China and that
has currently spread as a pandemic infection. It is characterized by fever, dry cough, headache, fatigue,
runny nose, conjunctivitis, anosmia, dysgeusia, and in severe cases, respiratory distress. It has a mortality rate of 4e5% in the groups at higher risk due to complications and the clinical evolution of the
infection. High-risk patients include people over 60 years-of-age, with associated comorbidity such as
systemic arterial hypertension, diabetes mellitus, obesity, patients with immunosuppression, patients
with treatments with immunosuppressants, smokers, patients with lung disease of any origin (COPD,
asthma and others), among others. Young people or people of any age are not exempt from being in the
4e5% of this case fatality.
Frequency of complications.
Complications associated with COVID-19 infection.
1.
2.
3.
4.
5.
6.
7.
8.

Acute Respiratory Distress Syndrome from 15 to 33%, in children it develops faster. Average Probability
Acute Liver Damage from 14 to 53% of severe cases with elevated transaminases. Average Probability
Cardiovascular Complications: Low probability
Acute cardiac damage of 7e20% with elevated cardiac markers, patients without acute cardiac damage
has a better prognosis.
Cardiomyopathy 33%.
Fulminant myocarditis, myopericarditis, cardiac tamponade.
Secondary Infections from 6 to 10%. Low probability
Acute Respiratory Failure in 8%. Low probability

It is the primary cause of mortality and is rapidly progressive in children.
1.
2.
3.
1.

Septic Shock from 4 to 8%. Low probability
Cytokine release syndrome. Low probability
Disseminated intravascular coagulation of 71% in patients who do not survive. Low probability
Rhabdomyolysis. Prognosis associated with COVID infection 19

General Mortality Rate: 5%.
Associated with comorbidities such as those mentioned bellow, it reaches 49%
1.
2.
3.
4.
5.
6.

Age: Over 60 years of age 6.4%
Diabetes Mellitus 7.3%
Lung or respiratory damage of 6.3%
Systemic Arterial Hypertension of 6%
Cancer of 5.6%
Cardiovascular disease 10.5%

The leading cause of death: Respiratory failure secondary to Acute Respiratory Distress Syndrome.
Prognosis based on the patient's clinical condition.
Poor prognosis factors:
1.
2.
3.
4.

Low albumin
High reactive C protein
Thrombocytopenia
Multi-organ failure.
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I fully understand the information on COVID-19 disease, the risk of being infected, complications,
prognosis, including its fatality. In accordance with NOM 004 / SSA3 / 2012, I do accept the procedure and/or
treatment proposed for my disease.
_______________________________________________
Name and signature of the Patient or Legally Responsible Person
___________________________________________
Name and signature of the reporting Physician
_________________________________ _________________________________
Name and signature of the Witness Name and signature of the Witness
__________________
Place and date.
I fully understand the information on COVID-19 disease, the risk of being infected, complications,
prognosis, including its fatality. In accordance with NOM 004 / SSA3 / 2012, I do not accept the procedure
and/or treatment proposed for my disease.
___________________________________________________
Name and signature of the Patient or Legal Responsible
___________________________________________
Name and signature of the reporting Physician
_________________________________ _________________________________
Name and signature of the Witness Name and signature of the Witness
____________________
Place and date
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